Dr Julio I Silva Ignacio, MD | |
San Jose # 26, Cabo Rojo, PR 00623 | |
(787) 323-4315 | |
Not Available |
Full Name | Dr Julio I Silva Ignacio |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | San Jose # 26, Cabo Rojo, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053320911 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 10135 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Julio I Silva Ignacio, MD Po Box 100, Cabo Rojo, PR 00623-0100 Ph: (787) 323-4315 | Dr Julio I Silva Ignacio, MD San Jose # 26, Cabo Rojo, PR 00623 Ph: (787) 323-4315 |
News Archive
Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.
UnitedHealthcare, one of the nation's biggest insurance companies, has decided to take a more active role in the care of its policy holders who are being treated for several types of cancer, The Wall Street Journal reports.
A major goal of hospitals is to prevent unplanned readmissions of patients after they are discharged. A new study reveals that the preventability of readmissions changes over time: readmissions within the first week after discharge are often preventable by the hospital, whereas readmissions later are often related to patients' difficultly accessing outpatient clinics.
The International Narcotics Control Board "remains out of step" with the rest of the United Nations' efforts to fight the spread of HIV, especially among injection drug users, and its practices should be open for review, Joanne Csete of the Canadian HIV/AIDS Legal Network and Daniel Wolfe, deputy director of Open Society Institute's International Harm Reduction Development program, write in a Lancet opinion piece.
› Verified 1 days ago